Abstract
Dr. Guido Zaman is Section Head Molecular in the Pharmacology Unit of N.V. Organon in Oss, the Netherlands. His section is responsible for assay development from cDNA to HTS, and in vitro biological testing from hit to clinical candidate. Guido completed his PhD in molecular biology on protein - RNA interaction at the University of Nijmegen in 1991, and studied multidrug resistance of human cancer cells at the Netherlands Cancer Institute in Amsterdam before joining Organon in 1996. In addition to serving as a guest editor of the mini-hot topic in this issue, Guido Zaman is a member of the Editorial Board of Assay & Drug Development Technologies.
Combinatorial Chemistry & High Throughput Screening
Title: Meet the Guest Editor
Volume: 8 Issue: 4
Author(s): Guido J.R. Zaman
Affiliation:
Abstract: Dr. Guido Zaman is Section Head Molecular in the Pharmacology Unit of N.V. Organon in Oss, the Netherlands. His section is responsible for assay development from cDNA to HTS, and in vitro biological testing from hit to clinical candidate. Guido completed his PhD in molecular biology on protein - RNA interaction at the University of Nijmegen in 1991, and studied multidrug resistance of human cancer cells at the Netherlands Cancer Institute in Amsterdam before joining Organon in 1996. In addition to serving as a guest editor of the mini-hot topic in this issue, Guido Zaman is a member of the Editorial Board of Assay & Drug Development Technologies.
Export Options
About this article
Cite this article as:
Zaman J.R. Guido, Meet the Guest Editor, Combinatorial Chemistry & High Throughput Screening 2005; 8 (4) . https://dx.doi.org/10.2174/1386207054020787
DOI https://dx.doi.org/10.2174/1386207054020787 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
C/EBP Transcription Factors in Lung Disease
Current Respiratory Medicine Reviews Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?
Current Neuropharmacology IP6 & Inositol in Cancer Prevention and Therapy
Current Cancer Therapy Reviews Anticancer Effects of Ginsenoside Rh2: A Systematic Review
Current Molecular Pharmacology Erlotinib in Non-Small Cell Lung Cancer: From a thought to Necessity
Clinical Cancer Drugs Phage Display Technology and its Applications in Cancer Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance
Current Medicinal Chemistry Advances in Noninvasive Pulmonary Gene Therapy
Current Drug Delivery Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry Editorial (Hot Topic: Synthetic, Natural and Related Compounds: New Approach to Chronic Diseases Studies)
Current Topics in Medicinal Chemistry Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology Stem Cell Transplantation and MBL Replacement Therapy
Current Stem Cell Research & Therapy Tankyrases: Structure, Function and Therapeutic Implications in Cancer
Current Pharmaceutical Design Biology and Clinical Relevance of Mannose-Binding Lectin
Drug Design Reviews - Online (Discontinued) Quinolones in the Search for New Anticancer Agents
Current Pharmaceutical Design Biodegradable Nanoparticles: A Recent Approach and Applications
Current Drug Targets Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Multi-modal Anti-cancer Activities Provided by a Non-replicating Sendai Virus Envelope
Current Cancer Therapy Reviews Regulation of Mesenchymal Phenotype by MicroRNAs in Cancer
Current Cancer Drug Targets